Molycorp (MCP +35.5%) shares are at the day's high after better-than-expected Q1 results, but at...
Molycorp (MCP +35.5%) shares are at the day's high after better-than-expected Q1 results, but at least some analysts remain cautious. Stifel Nicolaus cuts its 2013 earnings forecast on an assumed sales volume decline in part of MCP's business and more conservative pricing. Goldman Sachs shares concerns about pricing until the integration of its chlor-alkali plant later this year.
From other sites
at Benzinga.com (Jan 2, 2015)
at CNBC.com (Jul 4, 2014)
at CNBC.com (Jun 16, 2014)
at CNBC.com (Jun 4, 2014)
at CNBC.com (Apr 25, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs